Ceva Completes Deal to Acquire Portfolio of Merial Swine Vaccines and Nonsteroidal Anti-Inflammatories from Boehringer Ingelheim

GLOBAL - Ceva Santé Animale today completed the acquisition of a diversified portfolio of products, including swine and cattle vaccines and multi-species nonsteroidal anti-inflammatories from Boehringer Ingelheim following its acquisition of Merial Animal Health.
calendar icon 20 January 2017
clock icon 2 minute read

Ludmila Starostina

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.